Research Papers

25 of 2183 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
High Expression of WT1 and Low Expression of p53 in Archived Blocks of Children with Wilms Tumor in South Western Ugand…
Ssenkumba B; Atwiine B; Mitala Y; Adongo J; Olowo S; Nabulya R; Diaz Anaya A; Atwine R.
Cancer Manag Res (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Feasibility and Tolerability of Anlotinib Plus PD-1 Blockades for Patients with Treatment-Refractory Metastatic Colorec…
Bai H; Wang WH; Zhou FF; Yang D; Li RJ.
Cancer Manag Res (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
ZNF217: An Oncogenic Transcription Factor and Potential Therapeutic Target for Multiple Human Cancers.
Wang Y; Ma C; Yang X; Gao J; Sun Z.
Cancer Manag Res (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Correlation Between DCAMKL-1 Protein Expression and K-ras Gene Mutation in Colorectal Cancer.
Wu X; Li S; Yang Y; Hu J; Yang T.
Cancer Manag Res (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Resumption of Intravenous Anti-Cancer Therapy in Breast Cancer: A Real-World Experience During the SARS-CoV-2 Pandemic.
Yang F; Li C; Qiu Y; Chen X; Zheng K; Kang D; Zhang Y; Liu B; Yao Y; Xie L.
Cancer Manag Res (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Characteristics of Real-World Patients with High-Risk <i>BRAF</i><sup>V600E/K</sup>-Mutated Melanoma Receiving Adjuvant…
Quaglino P; Ascierto PA; Consoli F; Queirolo P; Spagnolo F; Morelli MF; Berardi R; Chiarion-Sileni V; Tucci M; Troiani T; Melotti B; Rossi E; Mandala M; Rinaldi G; Marcon IG; Pizzuti M; Del Vecchio M.
Cancer Manag Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Combining Clinicopathologic and Ultrasonic Features for Predicting Skip Metastasis of Lateral Lymph Nodes in Papillary …
Zhang X; Chen Y; Chen W; Zhang Z.
Cancer Manag Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Profile of Capmatinib for the Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC): Patient Selection and Perspec…
Fraser M; Seetharamu N; Diamond M; Lee CS.
Cancer Manag Res (Unknown)
Published: 2023
2/6 Transparent
Fecal Carriage of Extended-Spectrum β-Lactamase and Carbapenemase-Producing Enterobacteriaceae Among Oncology and Non-O…
Temsegen W; Gorems K; Mekonnen M; Fufa D; Kassa T.
Cancer Manag Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Navigating Sepsis: New Prognostic Tools [Letter].
Golcuk Y; Golcuk BK.
Cancer Manag Res (Unknown)
Published: 2023
2/6 Transparent
Construction of a Prognostic Model Based on Methylation-Related Genes in Patients with Colon Adenocarcinoma.
Liu Z; Xu Y; Jin S; Liu X; Wang B.
Cancer Manag Res (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
A New Scoring System for Predicting Mortality in Hematological Malignancies with Sepsis: A Derivation and Validation St…
Li H; Fan S; Lu D; Zhou J.
Cancer Manag Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Therapeutic Potential of Tisotumab Vedotin in the Treatment of Recurrent or Metastatic Cervical Cancer: A Short Report …
Agostinelli V; Musacchio L; Camarda F; Salutari V; Carbone MV; Ghizzoni V; Nero C; Ricci C; Perri MT; Giudice E; Lardino S; Berardi R; Scambia G; Lorusso D.
Cancer Manag Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The Incidence and Management of Cancer-Related Anorexia During Treatment with Vascular Endothelial Growth Factor Recept…
Takahashi S; Matsumoto K; Ohba K; Nakano Y; Miyazawa Y; Kawaguchi T.
Cancer Manag Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Clinical Utility of Ivosidenib in the Treatment of IDH1-Mutant Cholangiocarcinoma: Evidence To Date.
Uson Junior PLS; Borad MJ.
Cancer Manag Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Advances in Immunotherapy for the Treatment of Cutaneous T-Cell Lymphoma.
Pelcovits A; Ollila TA; Olszewski AJ.
Cancer Manag Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The Pro-Tumor Biological Function of IL-36α Plays an Important Role in the Tumor Microenvironment of HCC.
Song Y; Chu H; Liu F; Guo W; Gao N; Chen C; Bao S.
Cancer Manag Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Asciminib in the Treatment of Philadelphia Chromosome-Positive Chronic Myeloid Leukemia: Focus on Patient Selection and…
Hijiya N; Mauro MJ.
Cancer Manag Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Challenges and Strategies for Improving Access to Cancer Drugs in Malaysia: Summary of Opinions Expressed at the 2nd MA…
Tan SC; Poh WT; Yong ACH; Chua EW; Ooi J; Mahmud R; Thiagarajan M; Stanslas J.
Cancer Manag Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Potential Diagnostic Utility of microRNAs in Gastrointestinal Cancers.
Jelski W; Mroczko B.
Cancer Manag Res (Unknown)
Published: 2023
2/6 Transparent
Potential of Indonesian Herbal as an Anti-Cancer Therapy: A Systemic Review of in vitro Studies.
Permatasanti A; Hidayat W.
Cancer Manag Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The Circular RNA circFGFR4 Facilitates Resistance to Anti-PD-1 of Triple-Negative Breast Cancer by Targeting the miR-18…
Wang F; Lu Q; Yu H; Zhang XM.
Cancer Manag Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Exploring the Expression and Prognosis of Mismatch Repair Proteins and PD-L1 in Colorectal Cancer in a Chinese Cohort.
Han L; Zhang Y; Li L; Zhang Q; Liu Z; Niu H; Hu J; Ding Z; Shi X; Qian X.
Cancer Manag Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Spotlight on Cemiplimab-rwlc in the Treatment of Non-Small Cell Lung Cancer (NSCLC): Focus on Patient Selection and Con…
Ahn J; Nagasaka M.
Cancer Manag Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Management Strategies for Adults with Locally Advanced, Unresectable or Metastatic Malignant Perivascular Epithelioid C…
Czarnecka AM; Skoczylas J; Bartnik E; Świtaj T; Rutkowski P.
Cancer Manag Res (Unknown)
Published: 2023
2/6 Transparent